GLP-1RAs Linked to Reduced Haemorrhagic Stroke Risk: New Evidence Suggests Potential Neuroprotective Benefits
GLP-1RAs Linked to Reduced Haemorrhagic Stroke Risk: Glucagon-like peptide-1 receptor agonists (GLP-1RAs), a widely prescribed class of medications for type 2 diabetes, are gaining attention for benefits beyond glycaemic control. A 2026 retrospective cohort study has found that GLP-1RA prescriptions are associated with a reduced risk of aneurysmal rupture in patients living with type 2…